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Mesenchymal chondrosarcoma is a rare variant of chondrosarcomas characterized by a bimorphic pattern with areas of the
undifferentiated malignant small cells and well differentiated cartilaginous islands.1 It occurs most commonly in the bone
but can also occur in the extraskeletal soft tissues, the brain, and the meninges. This type of tumor has also been described
in the eyelids, parapharyngeal space, mediastinum, and the kidney.1-5 An origin from the large vessels has not been
reported in the medical literature. The authors report a case of mesenchymal chondrosarcoma originating from the
femoral vein in a 28-year-old female patient, treated by the wide-margin resection. (J Vasc Surg 2003;37:202-5.)
Mesenchymal chondrosarcoma is a highly malignant
tumor that follows a rapid clinical course with frequent
metastasis to the lung. The principle anatomic sites of
extraskeletal mesenchymal chondrosarcoma are the region
of the head and neck, the cranial and spinal dura mater,
followed by the low extremities.6-8 The thigh is the most
common site of extraskeletal mesenchymal chondrosar-
coma in the low extremities,1,6 and the involvement of the
muscle of the leg has been rarely observed. The authors
experienced the case of a 28-year-old female patient with a
firm lump at her proximal anteromedial thigh. Preoperative
computed tomography (CT), duplex study, and venogram
were helpful in defining intraluminal and extraluminal mass
of the femoral vein.
CASE REPORT
A 28-year-old female patient presented with a 1-month his-
tory of lump at the anteromedial aspect of the left thigh and left leg
edema. The mass was not painful. The patient denied any history of
trauma and her other medical history was unremarkable. On
physical examination, a firm 10- 4-cm mass was palpable deep to
the fascia in the thigh. There was no localized warmth, erythema,
bruising, or tenderness. No lymphadenopathy was present. CT
(Fig 1) showed a large lobulated mass in the superficial femoral
vein with scattered calcifications. The tumor extended intralumi-
nally beyond the orifice of the greater saphenous vein of the
femoral vein. The intraluminal mass extending to the common
femoral vein was somewhat movable when examined by real-time
duplex study. No evidence of deep vein thrombosis was noted in
other veins. The maximal venous outflow test showed the normal
ratio in both legs.
Operative findings. The operation was performed
with spinal block. A skin incision was made and dissection
was carried to the deep above and below the femoral vein.
A 10- 3.5- 3.5-cm firm mass of the superficial femoral
vein was found, which was adherent to the surrounding
quadriceps muscles.
The tumor encompassed the confluence of the superfi-
cial and deep femoral veins, but intraluminal mass was
movable (Fig 2, A). The mass was resected en bloc including
the superficial femoral vein and the surrounding soft tissue.
The proximal and distal ends of the vein margin were free of
tumor, which was confirmed by the frozen section evalua-
tion. The proximal femoral vein was repaired by angioplasty
method, allowing distal vein drainage through the greater
saphenous vein (Fig 2, B).
Pathologic findings. The tumor measured 10 cm in
greatest dimension and is mostly confined within the vas-
cular lumen. It was firm, well demarcated, multilobulated,
and attached to the surrounding soft tissues. The intralu-
minal portion of the mass was mostly pinkish-gray and
solid. Histologically, the tumor originated from the vascu-
lar wall and showed a bimorphic pattern composing areas of
the undifferentiated small cells and the well-differentiated
cartilaginous islands (Fig 3, B). Calcification and ossifica-
tion were present in some areas. Most of the mass was
confined in the intima, but focal invasion to adventitia was
also noted. The undifferentiated small cells had ovoid or
elongated hyperchromatic nuclei and scanty cytoplasm.
There was a prominent hemangiopericytic pattern. The
cartilaginous foci were relatively well-defined islands or
nodules of the benign appearing chondroid tissue (Fig 3,
A).
By immunohistochemistry, the undifferentiated small
tumor cells were strongly positive for CD99 but negative in
the cartilaginous areas (Fig 3, C) that showed immunore-
activity for S-100 protein but negative in the undifferenti-
ated small tumor cells. The positive reaction to CD31 was
limited to the vascular endothelial cells which confirmed
the tumor being within the vascular space.
Postoperative course. The patient had an uneventful
postoperative recovery and was discharged 1 week after
surgery. Bone scan and chest CT were performed 3 months
postoperatively and showed no distant metastasis.
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Fig 2. A, Operative findings. The tumor encompassed the confluence of the superficial and deep femoral veins.
B, Proximal femoral vein was repaired by angioplasty allowing distal vein drainage through saphenous vein. Arrow
shows the resected stump.
Fig 1. CT shows a multilobulated mass in the superficial femoral vein with scattered calcifications. The tumor
extended to the orifice of the greater saphenous vein and the femoral vein.
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DISCUSSION
Mesenchymal chondrosarcoma is a rare tumor, first
described by Lichtenstein and Bernstein9 in 1959 as a
primary bone sarcoma that comprises less than 2% of all
chondrosarcomas.1 This tumor is even less commonly dis-
covered in the extraskeletal soft tissues10 with brain and
meninges being involved more frequently. There appears
to be a predilection for the female sex and the young adult
age. Approximately 60% to 80% of mesenchymal chondro-
sarcoma occurs in the second and third decades of life.
Louvet et al11 reported a relation between the age of the
patient and the location of the tumor; the patients with
neural and muscular forms of the disease were younger than
those with mesenchymal chondrosarcoma arising from the
musculature.
Histologically, it is characterized by a bimorphic
pattern with sheets of the undifferentiated round-, oval-,
or spindle-shaped small cells and islands or the nodules
of benign-appearing cartilaginous tissue, frequently with
central calcification. The undifferentiated cells are ar-
ranged in small aggregated or hemangiopericytoma-like
pattern.12
Local recurrence usually precedes metastasis.13 Me-
tastasis of mesenchymal chondrosarcoma has been ob-
served in the regional and/or distant lymph nodes, and
the lungs as well as in the bones. Mesenchymal chondro-
sarcoma has a poor prognosis. Nakashima et al8 reported
5- and 10-year survival rates of 54.6% and 27.3%, respec-
tively. Huvos et al7 described a similar 10-year survival
rate. A wide-margin excision is a preferred treatment,1
and the role of chemotherapy and radiation remains
controversial.13-15
The authors’ experience of mesenchymal chondrosar-
coma originating from the femoral vein showed no evi-
dence of invasion to the surrounding structures. Salvage of
a tributary of the superficial femoral vein and greater saphe-
nous vein resulted in venous patency without graft interpo-
sition after resection of the tumor. We resected the tumor
with a sufficient margin.
In conclusion, we are reporting a case of mesenchymal
chondrosarcoma originating from the femoral vein in a
28-year-old female patient who was surgically treated with
a wide-margin resection. We are reporting the first case of
mesenchymal chondrosarcoma arising apparently from the
major vessel.
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